CasZyme

CasZyme is a startup company founded in 2017, headquartered in Vilnius, Lithuania. CasZyme aims to develop new discoveries, innovative applications, and high-quality research in the field of CRISPR-based molecular tools. The company is committed to creating exceptional value for researchers and companies worldwide engaged in gene editing. CasZyme was founded by scientists who were the first to demonstrate that CRISPR-Cas9 could be used to manipulate precise double-strand breaks in DNA, ushering in a new era of gene editing.